Chronic Myeloid Leukemia‎

Some Targeted Therapies May Miss the Mark

By

Caroline Seydel

Publish Date October 17, 2019

Ten different drugs continued to kill cancer cells even when their target proteins were removed.

Generic Imatinib Comparable to Original in Treatment of Chronic Myeloid Leukemia

By

Vicki Moore, PhD

Publish Date October 11, 2019

A retrospective study investigated whether safety and efficacy of generic imatinib is similar to the original form in the treatment of CML.

Blast Count Prognostic for CML Presenting in Advanced Phase

Publish Date October 1, 2019

Mortality risk significantly higher for patients with 20 to 29 percent versus less than 20 percent blasts.

Study Compares Quality of Life for Patients With Chronic Myeloid Leukemia Treated With Dasatinib vs Imatinib

By

Megan Garlapow, PhD

Publish Date September 16, 2019

Using validated assessment tools, researchers compared patients’ perceptions of HRQOL while undergoing treatment for CML with 1 of 2 TKIs.

Some Discrepancies Seen Between Real-Life and Guideline-Recommended Care of Chronic Myeloid Leukemia

By

Megan Garlapow, PhD

Publish Date August 20, 2019

An assessment of a population of patients with CML revealed that some are not receiving guideline-based treatment, including TKIs.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .